Thomas P. O'Neil

Chief Financial Officer, Arcadia Biosciences (United States).

Companies

Satsuma Pharmaceuticals, Inc.Chief financial officer Sep 12, 2019 to Jun 8, 2023¹
Protagonist Therapeutics, IncChief financial officer Aug 10, 2016 to Aug 17, 2018²
Arcadia Biosciences (United States)Chief financial officer May 14, 2015 to May 14, 2015³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Satsuma Pharmaceuticals, Inc.0 shares⁴Jun 6, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 6, 2023U 13,877 shares at $0.91 of Satsuma Pharmaceuticals, Inc.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARSatsuma Pharmaceuticals, Inc., Chief financial officer
2
SEC EDGARProtagonist Therapeutics, Inc, Chief financial officer
3
SEC EDGARArcadia Biosciences (United States), Chief financial officer
4
SEC EDGARSatsuma Pharmaceuticals, Inc. shares after the filing of Jun 6, 2023